TheraPanacea

Exhibitor

TheraPanacea develops AI-powered solutions for precision oncology, helping clinical teams turn complex imaging and multimodal patient data into actionable decisions across the cancer care pathway. Our technology supports clinicians from screening and diagnosis through treatment planning, therapy adaptation, and follow-up.

Our flagship platform, ART-Plan, acts as an AI companion to existing treatment planning systems, supporting automated segmentation, AI-assisted planning, and adaptive radiotherapy workflows. Beyond radiotherapy, TheraPanacea is expanding its clinical decision-support capabilities across oncology, including radioligand therapy and multimodal precision medicine.

By combining clinically validated AI, workflow integration, and close collaboration with leading cancer centres, TheraPanacea aims to reduce routine workload, improve consistency, and support more personalised treatment decisions for every patient.

website